Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease-Reference-Cited by-同舟云学术

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease

Published:2017-11-09 Issue:11 Volume:12 Page:e0187580
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martyanov Viktor^ORCID,Kim Grace-Hyun J.,Hayes Wendy,Du Shuyan,Ganguly Bishu J.,Sy Oumar,Lee Sun Ku,Bogatkevich Galina S.,Schieven Gary L.,Schiopu Elena,Marangoni Roberta Gonçalves,Goldin Jonathan,Whitfield Michael L.,Varga John

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Systemic sclerosis: a prototypic multisystem fibrotic disorder;J Varga;J Clin Invest,2007

2. Scleroderma: from pathophysiology to novel therapeutic approaches;N Hunzelmann;Exp Dermatol,2010

3. Changes in causes of death in systemic sclerosis, 1972–2002;VD Steen;Ann Rheum Dis,2007

4. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors;TA McNearney;Arthritis Rheum,2007

5. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?;EL Herzog;Arthritis Rheumatol,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Senescence and tissue fibrosis: opportunities for therapeutic targeting;Trends in Molecular Medicine;2024-06

2. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis;Molecular Aspects of Medicine;2024-04

3. What comes before scleroderma?;Systemic Sclerosis - Recent Advances and New Perspectives;2024-03-27

4. Targeting N4BP2L1 for Therapy in IPF and SSc-ILD: Evidence from Mendelian Randomization and Multi-Omics Analysis;2024

5. Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis;Scleroderma;2024